Remove Government Remove Networking Remove Pharmaceutical manufacturing Remove Pharmaceutical products
article thumbnail

Strengthening and transforming the pharmaceutical supply chain

European Pharmaceutical Review

In this Q&A EPR speaks to Naser Al Yammahi the Deputy CEO of Hayat Biotech about pharmaceutical supply chain challenges and how they can be addressed. Yammahi was instrumental in building Hayat’s extensive distribution network needed to supply vaccines during the COVID-19 pandemic. How can these issues be addressed?